A prospective study on single-port versus multiport patient-reported surgical outcomes.

Autor: Morgantini LA; Department of Urology University of Illinois at Chicago Chicago Illinois USA., Alzein A; Department of Urology University of Illinois at Chicago Chicago Illinois USA., Bharadwaj A; Department of Urology University of Illinois at Chicago Chicago Illinois USA., Del Pino MS; Department of Urology University of Illinois at Chicago Chicago Illinois USA., Egan E; Department of Urology University of Illinois at Chicago Chicago Illinois USA., Ganesh A; Department of Urology University of Illinois at Chicago Chicago Illinois USA., Smith J; Department of Urology University of Illinois at Chicago Chicago Illinois USA., Crivellaro S; Department of Urology University of Illinois at Chicago Chicago Illinois USA.
Jazyk: angličtina
Zdroj: BJUI compass [BJUI Compass] 2023 Sep 15; Vol. 5 (1), pp. 84-89. Date of Electronic Publication: 2023 Sep 15 (Print Publication: 2024).
DOI: 10.1002/bco2.290
Abstrakt: Introduction: We sought to determine potential patient reported advantages of the da Vinci single-port (SP) robotic system for urological procedures compared with the previous model, the da Vinci multiport (MP) system. The SP model utilizes a single 30 to 40 mm incision rather than multiple 5 to 22 mm incisions. This project aims to prospectively investigate the impact of the novel SP system on patient reported cosmetic and psychometric surgical outcomes.
Methods: We conducted a prospective study of patients who underwent uro-oncologic surgery by three urologists at the University of Illinois Chicago from April to November 2021. Study participants completed a Patient Scar Assessment Questionnaire 20 and 90 days post-procedure. The Patient Scar Assessment Questionnaire is a reliable measure of surgical scars that includes five subscales: Appearance, Symptoms, Consciousness, Satisfaction with Appearance, and Satisfaction with Symptoms. Higher scores represented worse reported outcomes.
Results: On Postoperative Day 20, there were 77 responses (53 SP and 24 MP). Patients receiving SP procedures reported more favourable outcomes in terms of appearance, symptoms, consciousness, and pain medication. On Day 90, there were 37 responses (24 SP and 13 MP). Patients receiving SP procedures reported more favourable outcomes in terms of appearance. No significant differences were seen on Day 90 in terms of pain, medication, symptoms, consciousness, or satisfaction.
Conclusions: This study demonstrates the superiority of the SP in patient reported cosmetic and pain outcomes on short- and long-term follow-up after uro-oncological surgical procedures. Symptomatic and cosmetic advantages are present at the 20 day follow-up, with better scar appearance being significant 90 days after surgery.
Competing Interests: There are no conflicts of interest to report.
(© 2023 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.)
Databáze: MEDLINE
Externí odkaz: